pyrazinoic acid has been researched along with Seizures in 1 studies
pyrazinoic acid: active metabolite of pyrazinamide; structure
pyrazine-2-carboxylic acid : The parent compound of the class of pyrazinecarboxylic acids, that is pyrazine bearing a single carboxy substituent. The active metabolite of the antitubercular drug pyrazinamide.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jimonet, P | 1 |
Bohme, GA | 1 |
Bouquerel, J | 1 |
Boireau, A | 1 |
Damour, D | 1 |
Debono, MW | 1 |
Genevois-Borella, A | 1 |
Hardy, JC | 1 |
Hubert, P | 1 |
Manfré, F | 1 |
Nemecek, P | 1 |
Pratt, J | 1 |
Randle, JC | 1 |
Ribeill, Y | 1 |
Stutzmann, JM | 1 |
Vuilhorgne, M | 1 |
Mignani, S | 1 |
1 other study available for pyrazinoic acid and Seizures
Article | Year |
---|---|
Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Combinatorial Ch | 2001 |